China SXT Pharmaceuticals, Inc. (SXTC): Price and Financial Metrics


China SXT Pharmaceuticals, Inc. (SXTC): $1.53

-0.10 (-6.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SXTC Stock Summary

  • With a market capitalization of $4,959,850, China SXT Pharmaceuticals Inc has a greater market value than only 0.17% of US stocks.
  • With a one year PEG ratio of 0.03, China SXT Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 0.38% of US stocks.
  • As for revenue growth, note that SXTC's revenue has grown -176.82% over the past 12 months; that beats the revenue growth of only 0.28% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to China SXT Pharmaceuticals Inc, a group of peers worth examining would be WILC, ITP, AKO.B, BVH, and GT.
  • Visit SXTC's SEC page to see the company's official filings. To visit the company's web site, go to www.sxtchina.com.

SXTC Valuation Summary

  • SXTC's price/sales ratio is 20.6; this is 442.11% higher than that of the median Healthcare stock.
  • SXTC's price/sales ratio has moved down 77.5 over the prior 32 months.
  • Over the past 32 months, SXTC's price/sales ratio has gone down 77.5.

Below are key valuation metrics over time for SXTC.

Stock Date P/S P/B P/E EV/EBIT
SXTC 2021-08-31 20.6 1.1 -6.6 -3.7
SXTC 2021-08-30 20.0 1.1 -6.4 -3.3
SXTC 2021-08-27 19.8 1.1 -6.4 -3.2
SXTC 2021-08-26 19.4 1.1 -6.3 -2.9
SXTC 2021-08-25 20.0 1.1 -6.4 -3.3
SXTC 2021-08-24 21.4 1.2 -6.9 -4.2

SXTC Stock Price Chart Interactive Chart >

Price chart for SXTC

SXTC Price/Volume Stats

Current price $1.53 52-week high $28.00
Prev. close $1.63 52-week low $1.26
Day low $1.46 Volume 98,500
Day high $1.65 Avg. volume 295,274
50-day MA $1.76 Dividend yield N/A
200-day MA $6.06 Market Cap 3.11M

China SXT Pharmaceuticals, Inc. (SXTC) Company Bio


China Sxt Pharmaceuticals, Inc. engages in the development, manufacture, marketing, sales, research and development of Chinese traditional medicine. It sells Advanced TCMP, Fine TCMP and Regular TCMP products. The company sell its products under "Suxuantang" brand name. The company was founded by Zhou Feng in 2005 and is headquartered in Taizhou, China.


SXTC Latest News Stream


Event/Time News Detail
Loading, please wait...

SXTC Latest Social Stream


Loading social stream, please wait...

View Full SXTC Social Stream

Latest SXTC News From Around the Web

Below are the latest news stories about China SXT Pharmaceuticals Inc that investors may wish to consider to help them evaluate SXTC as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, investor!

William White on InvestorPlace | March 1, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, trader!

William White on InvestorPlace | February 3, 2022

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).

NEW YORK, NY / ACCESSWIRE /January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.

Yahoo | January 20, 2022

China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the closing of an underwritten public offering (the “Of

Yahoo | January 20, 2022

China SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offering

China SXT Pharmaceuticals (SXTC) plunged 55.4% in premarket trade after it priced its earlier announced underwritten public offering of shares and prefunded warrants with gross

Seeking Alpha | January 18, 2022

Read More 'SXTC' Stories Here

SXTC Price Returns

1-mo -18.18%
3-mo -32.00%
6-mo -59.84%
1-year -93.11%
3-year -99.28%
5-year N/A
YTD -88.24%
2021 -50.54%
2020 -59.91%
2019 N/A
2018 N/A
2017 N/A

Continue Researching SXTC

Here are a few links from around the web to help you further your research on China SXT Pharmaceuticals Inc's stock as an investment opportunity:

China SXT Pharmaceuticals Inc (SXTC) Stock Price | Nasdaq
China SXT Pharmaceuticals Inc (SXTC) Stock Quote, History and News - Yahoo Finance
China SXT Pharmaceuticals Inc (SXTC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0428 seconds.